Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction

European Heart Journal: Acute Cardiovascular Care

Volumn 3, Issue 1, 2014, Pages 10-17

  Reinstadler, S J ^a   Klug, G ^a   Feistritzer, H J ^a   Mayr, A ^a   Bader, K ^a   Mair, J ^a   Esterhammer, R ^a   Schocke, M ^a   Metzler, B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adiponectin; aortic stiffness; cardiac magnetic resonance; pulse wave velocity; ST segment elevation myocardial infarction

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER;

ARTERIAL STIFFNESS; BLOOD; BLOOD FLOW VELOCITY; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; THORACIC AORTA;

ADIPONECTIN; AORTA, THORACIC; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; VASCULAR STIFFNESS;

EID: 84905113557     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872613516015     Document Type: Article

References (37)

1. Hui X, Lam KS, Vanhoutte PM, et al. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012; 165: 574–590.
2. Ntaios G, Gatselis NK, Makaritsis K, et al. Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 2013; 227: 216–221.
3. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737.
4. Frystyk J, Berne C, Berglund L, et al. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007; 92: 571–576.
5. El Khoudary SR, Barinas-Mitchell E, White J, et al. Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis 2012; 225: 475–480.
6. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005; 111: 3384–3390.
7. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664–670.
8. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.
9. George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006; 92: 1420–1424.
10. Cavusoglu E, Ruwende C, Chopra V, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006; 27: 2300–2309.
11. Lindberg S, Pedersen SH, Mogelvang R, et al. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2012; 109: 492–496.
12. Rathmann W Herder C. Adiponectin and cardiovascular mortality: evidence for ‘reverse epidemiology’. Horm Metab Res 2007; 39: 1–2.
13. Ikonomidis I, Kadoglou N, Tsiotra PC, et al. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens 2012; 25: 746–755.
14. Cavalcante JL, Lima JA, Redheuil A, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57: 1511–1522.
15. Grotenhuis HB, Westenberg JJ, Steendijk P, et al. Validation and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI. J Magn Reson Imag 2009; 30: 521–526.
16. Klug G Metzler B. Assessing myocardial recovery following ST-segment elevation myocardial infarction: short-and long-term perspectives using cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther 2013; 11: 203–219.
17. Hombach V, Merkle N, Bernhard P, et al. Prognostic significance of cardiac magnetic resonance imaging: update 2010. Cardiol J 2010; 17: 549–557.
18. Khan RS, Kato TS, Chokshi A, et al. Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail 2012; 5: 340–348.
19. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined – a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959–969.
20. Reinstadler SJ, Klug G, Feistritzer HJ, et al. Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction. Heart 2013; 99: 1525–1529.
21. Herold V, Parczyk M, Morchel P, et al. In vivo measurement of local aortic pulse-wave velocity in mice with MR microscopy at 17.6 Tesla. Magn Reson Med 2009; 61: 1293–9.
22. Ibrahim el SH, Johnson KR, Miller AB, et al. Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques. J Cardiovasc Magn Res 2010; 12: 26.
23. Gatzka CD, Cameron JD, Kingwell BA, et al. Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 1998; 32: 575–578.
24. Jilaihawi H, Greaves S, Rouleau JL, et al. Left ventricular hypertrophy and the risk of subsequent left ventricular remodeling following myocardial infarction. Am J Cardiol 2003; 91: 723–726.
25. Vakili BA, Okin PM Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141: 334–341.
26. van Popele NM, Mattace-Raso FU, Vliegenthart R, et al. Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study. J Hypertens 2006; 24: 2371–2376.
27. Kullo IJ, Bielak LF, Turner ST, et al. Aortic pulse wave velocity is associated with the presence and quantity of coronary artery calcium: a community-based study. Hypertension 2006; 47: 174–179.
28. Koenig W, Khuseyinova N, Baumert J, et al. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006; 48: 1369–1377.
29. Hashimoto N, Kanda J, Nakamura T, et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006; 55: 1653–1657.
30. Pilz S, Mangge H, Wellnitz B, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006; 91: 4277–4286.
31. Lindberg S, Mogelvang R, Pedersen SH, et al. Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study). Am J Cardiol 2013; 111: 1139–1145.
32. Mahmud A Feely J. Adiponectin and arterial stiffness. Am J Hypertens 2005; 18(12 Pt 1):1543–1548.
33. Park JS, Kang SA, Yoo JS, et al. Association between gamma-glutamyltransferase, adiponectin and arterial stiffness. J Atheroscl Thromb 2012; 19: 90–97.
34. Schnabel R, Messow CM, Lubos E, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008; 29: 649–657.
35. Furuhashi M, Ura N, Higashiura K, et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42: 76–81.
36. Sung SH, Chuang SY, Sheu WH, et al. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009; 103: 1411–1416.
37. von Eynatten M, Hamann A, Twardella D, et al. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 2006; 52: 853–859.